贝克曼库尔特

In this year’s #GWCChallenge, we’re challenging our students to build a project that explores how people can use AI to create a more sustainable future. We are on the edge of our seats while these projects are currently being judged by representatives from our incredible partners. The winners will be announced on 3/25 but in the meantime, let's introduce you to these amazing judges! Meet Nicole Shin McGee, Vice President of Information Technology and Chief Information Officer, at Beckman Coulter Diagnostics. “Diverse teams bring varied perspectives, which can lead to more innovative solutions and products,” says McGee. “By supporting Girls Who Code, we can collectively foster a culture of creativity and innovation within their organizations.? I am excited to participate in this event as AI and innovation will drive significant changes in the workforce by creating new opportunities, enhancing productivity, and enabling a more adaptive and resilient work environment."

Learn about our newly available high-throughput, fully automated immunoassay for plasma neurofilament light chain (NfL), a promising biomarker demonstrating neuro axonal damage in a variety of neurological conditions. With our newly available NfL assay, you can run up to 450 NfL tests/hour on the DxI 9000 analyzer and 100 NfL tests per hour on the Access 2 analyzer on both EDTA plasma and serum samples. How does our RUO assay compare with other commercially available NfL assays? Read the study to find out! ?? Download poster >>https://bit.ly/40TKtrQ ?? Learn more about our RUO assays>> https://bit.ly/40AxUQf #NeurologicalResearch #Healthcare #Diagnostics #NeurodegenerativeDisease

News Release: Beckman Coulter Announces FDA clearance of DxC 500i Clinical Analyzer, an integrated Clinical Chemistry and Immunoassay System https://bit.ly/41DwapJ #diagnostics, #clinicalchemistry #innovation

For International Women’s Day, how can you #AccelerateAction? Strike the #IWD2025 pose ??and show your support! At Danaher Corporation and Beckman Coulter, we have collaborated across our workforce to bring this theme to life in our programming, communications and events. We have worked diligently in prior years to achieve a richly varied workforce where our associates’ different backgrounds, experiences and perspectives have created a more inclusive workplace and a sense of belonging. However, there is always more we could do to actively demonstrate our core value, “Best Team Wins” and our core behavior “Win as a Team.” #IWD Kevin O'Reilly, Rachel Trace, Kiran Rathod, Grady Davis, Marianne Helstrup, Douglas Lee, Liezl Naude, Rasha Al Jayyousi, Sarah Foster, Peter Katona, Elaine Beliakoff, Vivienne Saunders, Brad Morse, Matthew Rhyner, Claudine Vo, SPHR, Erin Selin, Jose A. Crespo, Philipp Steinmann, Rob Young, Elke D?rner, Jin Yong, CPA, MBA, Jose Bermudez

It’s been a great two weeks in Athens and Orlando with our Europe and North America commercial teams. What an energizing start to 2025! We’re Relentless as One and poised to make a difference for our laboratory partners and the patients they serve. Special thanks to Rachel Trace , Matthew Miller and our leadership teams for hosting a warm welcome for our new Chief Commercial Officer?Laurent Amiel. I’m excited for what’s ahead for Beckman Coulter Diagnostics!?

While not diagnostic, understanding APOE ε4 status can provide insights into an individual’s risk for developing Alzheimer’s disease and may be a helpful test for scientists studying the risks of developing the disease. In this study from #CTAD2024, scientists evaluated the new Beckman Coulter APOE ε4 RUO immunoassay on the DxI 9000 and Access 2 analyzers and found 99% concordance with PCR. Read study summary: https://bit.ly/4ijybyf #APOEe4 #neurologicalresearch #neurodegenerativedisease #alzheimers

?? Join this webinar with #ADLM to learn about workflow optimization in healthcare. Experts Brittany Bedel and Brian Twarek will share how tech advancements like AI and automation are transforming TriHealth's network. Register here: https://bit.ly/41d65z0 #Healthcare #LabManagement #AI

Unlike traditional pathogen identification, host response to infection diagnostics also analyze biomarkers to provide a comprehensive view of the immune response. Read this blog from Melissa Naiman, PhD, EMT-B to learn how host response to infection diagnostics are changing how diseases are identified and treated. Read blog>> https://bit.ly/41hQXPE #emergencymedicine #infectionmanagement #hostresponse #diagnostics #sepsisdetection

Did you see our recent press release? We now have a pTau-217 assay available for RUO! This innovative biomarker is set to transform neurodegenerative disease research. Our comprehensive RUO biomarker portfolio now includes: ? p-Tau217 (phosphorylated Tau217) ? GFAP (Glial Fibrillary Acidic Protein) ? NfL (Neurofilament Light Chain) ? APOE ε4 (Apolipoprotein ε4) These assays provide a robust toolkit for advancing neurological research. ?? Check out our recent press release here >> https://bit.ly/3QB6t43 ?? Learn more about our RUO assays >> https://bit.ly/40AxUQf #BeckmanCoulter #Biomarkers #Neuroscience #Innovation #NeurodegenerativeDiseases #pTau217 #GFAP #NfL #APOEe4

“Host response to infection is the other side of the coin to pathogen identification. Host response biomarkers can do two things: they can help define the pathogen class that is most likely causing a patient’s symptoms, and they can help define the patient’s underlying immunological state.” Hear more from our own Melissa Naiman, PhD, about how decoding the host response can help unravel the complexities of infection and provide a deeper understanding of patient conditions. https://lnkd.in/eWM4EdUE #hostresponse #infectionmanagement #emergencymedicine #sepsis